Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Feb 10, 2009

Premium

Gyros moved Erik Walldén into the CEO and president positions, after he had served over the past year as acting CEO. Walldén previously has been CEO of Affibody Holding, CEO of Biacore International and Pyrosequencing, and he is a non-executive director of Exiqon, Proxeon, and VisEn Medical.


Strategic Diagnostics has appointed Monette Greenway to be VP of marketing and sales, and Robert Laffer to be sales manager for life sciences. Greenway will take over a spot that was left behind by Fran DiNuzzo, who was appointed CEO in November.

Greenway formerly was president of the Integrated Technologies Division of Thermo Fisher Scientific, and she was a VP and GM at Invitrogen. Laffer previously was a regional sales manager at Panomics, and he was a global account executive for the BioPharma division of PerkinElmer’s Life and Analytical Sciences.


David Jorden has been named to the board of Cytomedix. He was most recently with Morgan Stanley's Private Wealth Management group where he was responsible for equity portfolio management for high net worth individuals. Prior to Morgan Stanley, Jorden served as chief financial officer for Genometrix.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.